BIMI HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.23 USD | +3.36% |
|
-3.91% | -43.84% |
| Mar. 05 | Top Premarket Decliners | MT |
| Jan. 05 | BIMI International Medical, Inc. Announces Management Appointments | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6.861 | 119.1 | 28.94 | 21.09 | 18.65 | 4.673 |
| Enterprise Value (EV) 1 | 13.8 | 124.9 | 29.01 | 25.99 | 26.88 | 12.39 |
| P/E ratio | -4.37 x | -7.01 x | -5.87 x | -8.92 x | -0.39 x | -0.15 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.81 x | 18.2 x | 183 x | 1.64 x | 0.69 x | 0.4 x |
| EV / Revenue | 1.62 x | 19.1 x | 184 x | 2.02 x | 0.99 x | 1.05 x |
| EV / EBITDA | -55 x | -8.47 x | -22.9 x | -6.94 x | -3.42 x | -0.95 x |
| EV / FCF | -12.7 x | 17.5 x | 3.29 x | -4.56 x | 4.58 x | -2.21 x |
| FCF Yield | -7.9% | 5.71% | 30.4% | -21.9% | 21.8% | -45.2% |
| Price to Book | 0.25 x | 11.8 x | 3.33 x | 1.32 x | 1.94 x | 1.14 x |
| Nbr of stocks (in thousands) | 141 | 151 | 181 | 253 | 731 | 3,799 |
| Reference price 2 | 48.50 | 786.5 | 159.5 | 83.50 | 25.50 | 1.230 |
| Announcement Date | 3/30/18 | 8/30/19 | 5/14/20 | 3/31/21 | 4/15/22 | 5/4/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 8.508 | 6.542 | 0.158 | 12.84 | 27.08 | 11.83 |
| EBITDA 1 | -0.2511 | -14.75 | -1.267 | -3.747 | -7.866 | -12.99 |
| EBIT 1 | -1.195 | -15.79 | -1.529 | -3.803 | -8.107 | -13.21 |
| Operating Margin | -14.05% | -241.41% | -967.71% | -29.61% | -29.94% | -111.69% |
| Earnings before Tax (EBT) 1 | -1.576 | -17 | -2.269 | -3.352 | -34.9 | -21.62 |
| Net income 1 | -1.57 | -16.79 | -4.439 | -1.997 | -34.99 | -22.39 |
| Net margin | -18.45% | -256.59% | -2,809.61% | -15.55% | -129.2% | -189.29% |
| EPS 2 | -11.10 | -112.2 | -27.17 | -9.356 | -65.24 | -8.404 |
| Free Cash Flow 1 | -1.091 | 7.128 | 8.821 | -5.696 | 5.868 | -5.604 |
| FCF margin | -12.82% | 108.95% | 5,583.78% | -44.35% | 21.67% | -47.37% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/30/18 | 8/30/19 | 5/14/20 | 3/31/21 | 4/15/22 | 5/4/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 6.94 | 5.8 | 0.07 | 4.9 | 8.24 | 7.72 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -27.65 x | -0.393 x | -0.0561 x | -1.307 x | -1.047 x | -0.5941 x |
| Free Cash Flow 1 | -1.09 | 7.13 | 8.82 | -5.7 | 5.87 | -5.6 |
| ROE (net income / shareholders' equity) | -5.85% | -91.2% | -24.5% | -29.8% | -247% | -261% |
| ROA (Net income/ Total Assets) | -1.9% | -30.6% | -3.6% | -7.51% | -14.2% | -22.4% |
| Assets 1 | 82.76 | 54.83 | 123.4 | 26.58 | 246.3 | 100.1 |
| Book Value Per Share 2 | 193.0 | 66.90 | 47.80 | 63.00 | 13.20 | 1.080 |
| Cash Flow per Share 2 | 1.990 | 0.1200 | 0.2000 | 0.5100 | 5.640 | 0.6200 |
| Capex | - | - | - | 0.26 | 0.81 | - |
| Capex / Sales | - | - | - | 2.02% | 3.01% | - |
| Announcement Date | 3/30/18 | 8/30/19 | 5/14/20 | 3/31/21 | 4/15/22 | 5/4/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -43.84% | 17.22M | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B |
- Stock Market
- Equities
- BIMI Stock
- Financials BIMI Holdings Inc.
